![]() ![]() “The rapid identification of bloodstream infections and the detection of antimicrobial resistance genes are more essential than ever for hospitals and their patients. “Their proven expertise in syndromic panel testing provides faster targeted therapeutic intervention, resulting in improved patient outcomes and reduced hospital stays, and will contribute to Roche’s commitment to helping control infectious diseases and antibiotic resistance. Roche Diagnostics CEO Thomas Schinecker said: “Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases. The Genmark’s Open Cassette Adapter (OCA) is an option for our load-ports tools that allows order-technology open wafer cassettes on newer tools. Key Tech was proud to play a role in the multi-partner. The goal for the development program was to create a next-generation diagnostic platform that could accomplish complex tests while making it incredibly simple for the user. (GNF.F) stock quote, history, news and other vital information to help you with your stock trading and investing. GenMark’s ePlex® System is a state-of-the-art sample-to-answer molecular diagnostic test for infectious diseases. ![]() GenMark’s Respiratory Pathogen Panels can detect the most common viral and bacterial organisms associated with an upper respiratory infection, including SARS-CoV-2, complementing Roche’s Covid-19 diagnostics solutions portfolio. Find the latest GenMark Diagnostics, Inc. Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a 1.8 billion deal, the Swiss pharmaceuticals manufacturer said on Monday. The HCVg Direct Test is designed to type and subtype Hepatitis C virus (HCV) 1a, 1b, 2, 2a/c. The products presented in this section are available only in the U.S. We are a leading worldwide developer and manufacturer of tool and fab automation equipment solutions for the semiconductor, flat panel, solar, LED, data storage, and associated industries. The addition of the company’s syndromic panel testing portfolio expands Roche’s molecular diagnostics portfolio. GenMark Diagnostics is committed to meeting customer needs with a broad menu of multiplex molecular products.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |